TY  - JOUR
AU  - Martín Ramos, Silvia
AU  - Gil-Calvo, Marta
AU  - Roldán, Virginia
AU  - Castellano Martínez, Ana
AU  - Santos, Fernando
PY  - 2020
DO  - 10.3389/fped.2020.00048
SN  - 2296-2360
UR  - http://hdl.handle.net/10668/15203
T2  - Frontiers in pediatrics
AB  - X-linked hypophosphatemia (XLH) causes significant burden in pediatric patients in spite of maintained treatment with phosphate supplements and vitamin D derivatives. Administration of burosumab has shown promising results in clinical trial but...
LA  - en
KW  - FGF23
KW  - X-linked hypophosphatemia (XLH)
KW  - burosumab
KW  - children
KW  - hypophosphatemia
KW  - rickets
KW  - vitamin D
TI  - Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia.
TY  - research article
VL  - 8
ER  -